Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer

Completed · Early Phase 1

Conditions studied: Head and Neck Cancer

In brief

The purpose of this study is to obtain preliminary information on the potential of 99m Tc-EC-DG SPECT imaging to distinguish cancer from non cancer.

Key facts

Study ID

NCT01359267

Run by

University of Chicago

People needed

12

Starts

2011-04-19

Expected to finish

2015-09-15

Last updated by the study team

2020-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Treatment naive patients with histologically proven cancer of the head and neck
• T4 primary tumor (all sites), N2 or N3 locoregional disease (all sites)
• At least one measurable site of disease
• At least 18 years of age
• Karnofsky performance status > or = 70% or ECOG <2
• Able to tolerate SPECT/CT imaging
• Adequate bone marrow function
• Adequate liver function
• Adequate renal function
• Written consent from patients
• Female patients of childbearing potential must have a negative pregnancy test within 0-7 days prior to the first SPECT study

You may not qualify if…

• Diabetics with insulin dependence or blood sugar levels >200 mg/dL prior to imaging
• Patient weight above the SPECT/CT table weight limit
• Pregnant and/or lactating female
• Unequivocal demonstration of metastatic disease
• Patients unwilling to or unable to comply with protocol

Where it is running

• University of Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.